MediWound (MDWD) Capital Expenditures (2013 - 2026)

MediWound has reported Capital Expenditures for 14 years, with the latest figure at -$1.1 million in Q2 2026.

• On a quarterly basis, Capital Expenditures fell 2.38% year-over-year to -$1.1 million in Q2 2026; TTM through Jun 2026 was -$6.4 million, a 59.54% decrease from a year earlier, with the FY2025 full-year figure at -$5.5 million, up 12.24% from the prior year.
• Capital Expenditures was -$1.1 million for Q2 2026 at MediWound, up from -$1.8 million in the prior quarter.
• The five-year high for Capital Expenditures was -$83000.0 in Q3 2022, with the low at -$3.0 million in Q2 2024.
• Average Capital Expenditures over 5 years is -$1.2 million, with a median of -$1.1 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2025: Capital Expenditures slumped 1930.12% in 2023, then jumped 65.22% in 2025.
• Over 5 years, Capital Expenditures stood at -$174000.0 in 2022, then plunged by 1169.54% to -$2.2 million in 2023, then soared by 63.51% to -$806000.0 in 2024, then tumbled by 204.22% to -$2.5 million in 2025, then surged by 56.2% to -$1.1 million in 2026.
• The last three Capital Expenditures figures came in at -$1.1 million (Q2 2026), -$1.8 million (Q1 2026), and -$2.5 million (Q4 2025), per Business Quant data.